Lanean...
Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure
The coronavirus disease (COVID-19) pandemic is a global health priority. Given that cardiovascular diseases (CVD) are the leading cause of morbidity around the world and that several trials have reported severe cardiovascular damage in patients infected with SARS-CoV-2, a substantial number of COVID...
Gorde:
| Argitaratua izan da: | Heart Fail Rev |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer US
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7447089/ https://ncbi.nlm.nih.gov/pubmed/32844337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10741-020-10016-2 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|